Table of Content

Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL EPOETIN-ALFA ERYTHROPOIETIN INDUSTRY
2.1 Summary about Epoetin-alfa Erythropoietin Industry
2.2 Epoetin-alfa Erythropoietin Market Trends
2.2.1 Epoetin-alfa Erythropoietin Production & Consumption Trends
2.2.2 Epoetin-alfa Erythropoietin Demand Structure Trends
2.3 Epoetin-alfa Erythropoietin Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Anemia
4.2.2 Kidney Disorders
4.2.3 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Hospital
4.3.2 Clinic
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Anemia
5.2.2 Kidney Disorders
5.2.3 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Hospital
5.3.2 Clinic
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Anemia
6.2.2 Kidney Disorders
6.2.3 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Hospital
6.3.2 Clinic
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Anemia
7.2.2 Kidney Disorders
7.2.3 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Hospital
7.3.2 Clinic
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Anemia
8.2.2 Kidney Disorders
8.2.3 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Hospital
8.3.2 Clinic
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Anemia
9.2.2 Kidney Disorders
9.2.3 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Hospital
9.3.2 Clinic
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Amgen
10.1.2 Johnson & Johnson
10.1.3 Roche
10.1.4 Galenica
10.1.5 Emcure
10.1.6 Kyowa Hakko Kirin
10.1.7 3SBio
10.1.8 Biocon
10.1.9 LG Life Sciences
10.2 Epoetin-alfa Erythropoietin Sales Date of Major Players (2017-2020e)
10.2.1 Amgen
10.2.2 Johnson & Johnson
10.2.3 Roche
10.2.4 Galenica
10.2.5 Emcure
10.2.6 Kyowa Hakko Kirin
10.2.7 3SBio
10.2.8 Biocon
10.2.9 LG Life Sciences
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT

List of Figure

List of Table
Table Epoetin-alfa Erythropoietin Product Type Overview
Table Epoetin-alfa Erythropoietin Product Type Market Share List
Table Epoetin-alfa Erythropoietin Product Type of Major Players
Table Brief Introduction of Amgen
Table Brief Introduction of Johnson & Johnson
Table Brief Introduction of Roche
Table Brief Introduction of Galenica
Table Brief Introduction of Emcure
Table Brief Introduction of Kyowa Hakko Kirin
Table Brief Introduction of 3SBio
Table Brief Introduction of Biocon
Table Brief Introduction of LG Life Sciences
Table Products & Services of Amgen
Table Products & Services of Johnson & Johnson
Table Products & Services of Roche
Table Products & Services of Galenica
Table Products & Services of Emcure
Table Products & Services of Kyowa Hakko Kirin
Table Products & Services of 3SBio
Table Products & Services of Biocon
Table Products & Services of LG Life Sciences
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Epoetin-alfa Erythropoietin Market Forecast (Million USD) by Region 2021f-2026f
Table Global Epoetin-alfa Erythropoietin Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Epoetin-alfa Erythropoietin Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Epoetin-alfa Erythropoietin Market Forecast (Million USD) Share by Demand 2021f-2026f